NEFRX vs. AMFIX

Last updated Apr 1, 2026

Compare and contrast key facts about Loomis Sayles Core Plus Bond Fund (NEFRX) and AAMA Income Fund (AMFIX).

NEFRX is managed by Natixis. It was launched on Nov 7, 1973. AMFIX is managed by AAMA. It was launched on Jun 30, 2017.

Performance

NEFRX vs. AMFIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loomis Sayles Core Plus Bond Fund (NEFRX) and AAMA Income Fund (AMFIX). The values are adjusted to include any dividend payments, if applicable.

NEFRX vs. AMFIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NEFRX Loomis Sayles Core Plus Bond Fund	-0.64%	7.24%	0.60%	5.91%	-12.94%	-1.68%	10.29%	8.76%	-0.86%	0.69%
AMFIX AAMA Income Fund	0.21%	3.74%	3.48%	3.84%	-6.26%	-1.37%	2.24%	2.47%	0.89%	-0.44%

Returns By Period

In the year-to-date period, NEFRX achieves a -0.64% return, which is significantly lower than AMFIX's 0.21% return.

NEFRX

• 1D: 0.53%
• 1M: -2.39%
• YTD: -0.64%
• 6M: 0.26%
• 1Y: 3.67%
• 3Y*: 3.06%
• 5Y*: 0.06%
• 10Y*: 2.26%

AMFIX

• 1D: 0.17%
• 1M: -0.49%
• YTD: 0.21%
• 6M: 1.06%
• 1Y: 2.97%
• 3Y*: 3.23%
• 5Y*: 0.72%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NEFRX vs. AMFIX - Expense Ratio Comparison

NEFRX has a 0.71% expense ratio, which is lower than AMFIX's 0.92% expense ratio.

AMFIX

AAMA Income Fund

NEFRX

Loomis Sayles Core Plus Bond Fund

Return for Risk

NEFRX vs. AMFIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEFRX

NEFRX Risk / Return Rank: 67
NEFRX Sharpe Ratio Rank: 62
NEFRX Sortino Ratio Rank: 64
NEFRX Omega Ratio Rank: 50
NEFRX Calmar Ratio Rank: 85
NEFRX Martin Ratio Rank: 74

AMFIX

AMFIX Risk / Return Rank: 98
AMFIX Sharpe Ratio Rank: 98
AMFIX Sortino Ratio Rank: 98
AMFIX Omega Ratio Rank: 97
AMFIX Calmar Ratio Rank: 97
AMFIX Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEFRX vs. AMFIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and AAMA Income Fund (AMFIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NEFRX	AMFIX	Difference
Sharpe ratio Return per unit of total volatility	1.10	3.05	-1.95
Sortino ratio Return per unit of downside risk	1.62	4.95	-3.33
Omega ratio Gain probability vs. loss probability	1.20	1.69	-0.49
Calmar ratio Return relative to maximum drawdown	2.13	4.18	-2.05
Martin ratio Return relative to average drawdown	7.08	21.12	-14.03
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NEFRX vs. AMFIX - Sharpe Ratio Comparison

The current NEFRX Sharpe Ratio is 1.10, which is lower than the AMFIX Sharpe Ratio of 3.05. The chart below compares the historical Sharpe Ratios of NEFRX and AMFIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NEFRX	AMFIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.10	3.05	-1.95
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.01	0.34	-0.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.46	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.73	0.56	+0.17

Correlation

The correlation between NEFRX and AMFIX is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

NEFRX vs. AMFIX - Dividend Comparison

NEFRX's dividend yield for the trailing twelve months is around 3.64%, more than AMFIX's 2.22% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NEFRX Loomis Sayles Core Plus Bond Fund	3.64%	3.97%	3.90%	3.58%	3.10%	2.34%	4.04%	2.51%	2.87%	2.68%	3.17%	2.58%
AMFIX AAMA Income Fund	2.22%	2.08%	2.44%	1.70%	0.83%	0.57%	0.83%	1.24%	1.24%	0.40%	0.00%	0.00%

Drawdowns

NEFRX vs. AMFIX - Drawdown Comparison

The maximum NEFRX drawdown since its inception was -25.45%, which is greater than AMFIX's maximum drawdown of -9.35%. Use the drawdown chart below to compare losses from any high point for NEFRX and AMFIX.

Drawdown Indicators

	NEFRX	AMFIX	Difference
Max Drawdown Largest peak-to-trough decline	-25.45%	-9.35%	-16.10%
Max Drawdown (1Y) Largest decline over 1 year	-3.12%	-0.74%	-2.38%
Max Drawdown (5Y) Largest decline over 5 years	-18.55%	-8.91%	-9.64%
Max Drawdown (10Y) Largest decline over 10 years	-18.76%	—	—
Current Drawdown Current decline from peak	-2.82%	-0.49%	-2.33%
Average Drawdown Average peak-to-trough decline	-3.97%	-2.06%	-1.91%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.94%	0.15%	+0.79%

Volatility

NEFRX vs. AMFIX - Volatility Comparison

Loomis Sayles Core Plus Bond Fund (NEFRX) has a higher volatility of 1.47% compared to AAMA Income Fund (AMFIX) at 0.48%. This indicates that NEFRX's price experiences larger fluctuations and is considered to be riskier than AMFIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NEFRX	AMFIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.47%	0.48%	+0.99%
Volatility (6M) Calculated over the trailing 6-month period	2.86%	0.72%	+2.14%
Volatility (1Y) Calculated over the trailing 1-year period	4.99%	0.98%	+4.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	6.19%	2.16%	+4.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5.02%	1.75%	+3.27%